• Treatment of Moderate to Severe Plaque Psoriasis: Amevive is primarily indicated for the treatment of moderate to severe plaque psoriasis in adults. 
• Alternative for Non-Responsive Patients: It is often prescribed for patients who have not responded adequately to other treatments such as topical creams, phototherapy, or systemic medications. For individuals with resistant or difficult-to-treat psoriasis, Amevive offers a therapeutic option that targets the underlying immune system dysfunction.
• Monotherapy or Combination Therapy: Amevive can be used as monotherapy, meaning it is the sole treatment prescribed for psoriasis. Alternatively, it may be used in combination with other psoriasis medications or therapies, depending on the severity of the condition and the patient’s response to treatment. Combination therapy may enhance efficacy and improve outcomes for some patients.
• Long-Term Management: In some cases, Amevive is used for long-term management of psoriasis to maintain remission and prevent disease flare-ups. This may involve periodic treatment courses or maintenance dosing schedules tailored to the individual patient’s needs.
• Not Indicated for Children or Adolescents: It’s important to note that Amevive is not approved for use in children or adolescents due to limited safety and efficacy data in this population. Its use is specifically intended for adults with moderate to severe plaque psoriasis who have not responded to other treatments or who cannot tolerate alternative therapies.

• Targeted Immunosuppression: Amevive, or alefacept, is a biologic medication that exerts its therapeutic effects by selectively targeting and modulating the immune system’s response. It specifically acts on a subset of white blood cells known as CD4+ T-cells, which play a central role in orchestrating the inflammatory process seen in psoriasis.
• Reduction of Activated T-cells: By binding to CD2 receptors on the surface of activated T-cells, Amevive inhibits their activation and proliferation. This leads to a reduction in the number of circulating pathogenic T-cells involved in the inflammatory cascade characteristic of psoriasis.
• Induction of Apoptosis: A key mechanism of action of Amevive is its ability to induce apoptosis, or programmed cell death, in activated T-cells. This helps to reduce the overall inflammatory burden in the skin, leading to a decrease in psoriatic plaques and symptoms.
• Gradual Improvement: Amevive therapy typically involves a gradual improvement in psoriasis symptoms over the course of treatment. While some patients may experience noticeable results within a few weeks, maximum benefit is often achieved with continued therapy over several months.
• Maintenance of Remission: In addition to its therapeutic effects during active treatment, Amevive may also help to maintain remission in patients with psoriasis, reducing the frequency and severity of flare-ups when used as part of a long-term management strategy.
•  

Common Side Effects:

• Injection site reactions such as redness, swelling, or pain may occur but are usually mild and transient.
• Headache, nausea, and flu-like symptoms are reported by some patients during treatment but often improve over time.

Serious Side Effects:

• Immunosuppression: Amevive may increase the risk of infections, including bacterial, viral, and fungal infections. Patients should be monitored closely for signs of infection during treatment.
• Hepatotoxicity: Rare cases of liver injury, including elevated liver enzymes and hepatitis, have been reported with Amevive therapy. Liver function tests should be performed regularly to monitor for potential hepatotoxicity.
• Hypersensitivity Reactions: Severe allergic reactions, including anaphylaxis, have been reported with Amevive. Patients should be monitored for signs of hypersensitivity, and treatment should be discontinued if a reaction occurs.

It’s important for patients to discuss any concerns or potential side effects with their healthcare provider before starting Amevive therapy.

• Prioritize the use of Amevive in patients with no history of tuberculosis, as it may exacerbate latent infections.
• Use caution in patients with a history of malignancy due to the potential for immunosuppression and increased risk of malignancies.

• Amevive may increase the risk of serious infections, including reactivation of latent tuberculosis or development of opportunistic infections.
• Amevive is contraindicated in patients with hypersensitivity to the active ingredient or any component of the formulation.

• Immunosuppressive Medications:Concurrent use of Amevive with other immunosuppressive medications, such as corticosteroids or methotrexate, may increase the risk of immunosuppression and susceptibility to infections. Close monitoring for signs of infection is recommended.
• Live Vaccines:Amevive may interfere with the efficacy of live vaccines. Patients receiving Amevive should avoid live vaccines during treatment and for at least 12 weeks after discontinuation of therapy.
• Biologic Agents:Co-administration of Amevive with other biologic agents targeting the immune system may increase the risk of immunosuppression and adverse effects. Use caution and monitor patients closely for signs of infection or other complications.
• Hepatotoxic Drugs:Drugs known to cause hepatotoxicity, such as certain antibiotics or antifungals, should be used with caution in patients receiving Amevive. Regular monitoring of liver function tests is recommended to detect potential hepatotoxicity.
• Concomitant Therapy:Patients should inform their healthcare provider about all medications, including over-the-counter drugs and herbal supplements, they are taking before starting Amevive therapy to assess potential drug interactions and adjust treatment as necessary.

• Initial Dosing:The recommended initial dose of Amevive is typically administered as a weekly intramuscular injection for 12 weeks.
• Maintenance Therapy:Following the initial treatment course, some patients may benefit from maintenance therapy with Amevive, which involves less frequent dosing to sustain therapeutic effects.
• Dosage Adjustment:Dosage adjustments may be necessary based on individual patient response, disease severity, and tolerability.
• Administration:Amevive injections should be administered by a healthcare professional in a clinical setting to ensure proper technique and patient safety.
• Monitoring:Patients should be monitored regularly during treatment for efficacy, safety, and any potential adverse effects.

• Healthcare Provider Prescription: Amevive is available only with a valid prescription from a licensed healthcare provider, such as a dermatologist or rheumatologist.
• Specialist Consultation: Due to the specific indications and potential side effects of Amevive, patients typically require evaluation by a specialist familiar with the management of psoriasis or related conditions.
• Prior Authorization: Insurance coverage for Amevive may require prior authorization from the patient’s insurance provider, which may involve documentation of the medical necessity of the treatment.

What is Amevive?

Amevive is a medication used to treat moderate to severe plaque psoriasis by suppressing the immune system to reduce inflammation and skin plaques.

How does Amevive work?

Amevive works by targeting and depleting certain T cells that are involved in the inflammatory process of psoriasis, helping to reduce the symptoms of the disease.

Who is a good candidate for Amevive treatment?

Amevive is typically prescribed for adults with moderate to severe plaque psoriasis who have not responded to other treatments or who cannot use other therapies due to side effects.

How is Amevive administered?

Amevive is given as an injection, typically under the skin, and is usually administered once a week for a set duration.

What are the common side effects of Amevive?

Common side effects include injection site reactions, headache, throat infections, and flu-like symptoms.

Can Amevive cause serious side effects?

Yes, serious side effects can include increased risk of infections, allergic reactions, and changes in blood cell counts, which may necessitate monitoring.

What should I do if I miss a dose of Amevive?

If you miss a dose, administer it as soon as you remember. If it’s almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double up.

Is Amevive safe during pregnancy?

The safety of Amevive during pregnancy is not fully established. It should only be used if the potential benefit justifies the risk to the fetus.

Can I use Amevive while breastfeeding?

It is not known if Amevive passes into breast milk. Consult your doctor to weigh the benefits against potential risks.

How long does it take to see results from Amevive?

Patients may notice improvements in their psoriasis symptoms within 12 weeks of starting treatment, although responses can vary.

Can I still take other medications while on Amevive?

You should inform your healthcare provider about all medications you are taking, as some may interact with Amevive or increase the risk of side effects.

How should I store Amevive?

Amevive should be stored in the refrigerator and protected from light. It should not be frozen, and any unused medication should be discarded after its expiration date.

What tests are required before starting Amevive?

Before starting Amevive, patients typically undergo tests for current infections and blood counts to ensure they are fit for treatment.

Are there any conditions that would prevent me from using Amevive?

Conditions like a known hypersensitivity to alefacept, active infections, and certain types of cancers may contraindicate the use of Amevive.

Can Amevive affect my immune system?

Yes, because Amevive targets T cells, it can lower your immune system’s ability to fight infections, making you more susceptible to illness.

What are the long-term effects of using Amevive?

Long-term use can lead to serious infections or issues with immune function, so regular monitoring by a healthcare provider is essential.

Can I travel while undergoing Amevive treatment?

Yes, but you should plan your injections around your travel schedule, and ensure you have access to refrigeration for the medication.

What should I do if I experience an allergic reaction to Amevive?

Seek immediate medical attention if you develop symptoms of an allergic reaction, such as rash, itching, swelling, or difficulty breathing.

Is there a risk of developing skin cancer while on Amevive?

Some studies suggest an increased risk of skin cancer with long-term use of immunosuppressive therapies, including Amevive, so regular skin checks are recommended.

What lifestyle changes can support my Amevive treatment?

Maintaining a healthy diet, staying hydrated, managing stress, and avoiding known psoriasis triggers can help enhance the effectiveness of Amevive treatment.